In tumoral B cell lines, including DLBCL cell lines, EBI3 expression has been shown to be dependent on NF-κB activation, and in EBV-transformed B cells to be induced by LMP1 in an NF-κB dependent manner [14], [16], [28]. Here, EBI3 is linked to diffuse large B-cell lymphoma.